Amgen: Top Performing on the Nasdaq 100

In this video

Share

Amgen: Top Performing on the Nasdaq 100

CNBC's Seema Mody reports on big movers in Biotech after Affymax and Takeda recalled an anemia drug named Omontys.
01:18
Mon, Feb 25 20131:38 PM EST